White Papers & Resources

Ben Bonifant, Jeff Stewart
The 2011 Dealmakers' Intentions Survey is the only forward-looking measure of deal-making activity in the pharma and biotech industries. Download a summary of the results.
Read article

Kuyler Doyle, Tony Lanzone, and Fahti Khosrow-Shahi
This article examines the current movement toward an abbreviated approval pathway for follow-on biologics in the US and assesses the potential impact on current biotechnology products.
Read article

This white paper explores how various industry trends are affecting pharma's customers, and what it means for training departments. This paper was written to capture the outputs of a workshop that Campbell Alliance led at the 2010 annual meeting of the SPBT
Read article

Gary Tyson and Mike Menta
Gary Tyson and Mike Menta show how Medical Affairs leaders can find new and better ways to define, measure, and communicate the value of their organization’s function to the rest of the company.
Read article

Gary Tyson, Senior Vice President, Clinical Development Practice
Gary Tyson, Senior Vice President and head of our Clinical Development Practice, suggests ways to improve the relationship between CROs and sponsors
Read article

Mike Menta
This article addresses how to enhance efficiency in today's challenging, resource-constrained environment.
Read article

Gary Tyson, Mike Menta
This white paper offers effective strategies for maximizing the effectiveness of Medical Science Liaisons (MSLs)
Read article

Fahti Khosrow-Shahi, Emily Hua, and Jemma Richards
Senior Vice President, Vice President, and Consultant, Brand Management Practice
The glory days of big blockbuster products are waning. Quickly emerging, however, is a market that is characterized by rigorous complexities and relentless competition in which pharmaceutical executives are forced to explore new options for maximizing product potential throughout the life cycle. By focusing on creating strategic commercialization plans earlier in the drug development process, executives are hoping to better prime each product for success.
Read article

Campbell Alliance Market Research and Analytics
The MPA™ Detail Trends Report provides a snapshot of the detailing activity of the most heavily promoted pharmaceutical brands. The detail trend data from the November 2011 rolling-quarter was captured by the MPA™ Sales Force Promotion Audit.
Read article

Jeff Stewart, Nader Naeymi-Rad
This report summarizes the results of Campbell Alliance's ONC study, detailing 10 trends that will make the oncology market more challenging in the coming years
Read article

Gary Tyson, Mike Menta
Most clinical development teams must be cross-functional, which means that members can have different goals and matrixed reporting relationships. This white paper helps address the challenges associated with these matrixed teams.
Read article

Gary Tyson and Kuyler Doyle
To assess the evolving role of Medical Affairs and evaluate current organizational structures, responsibilities, and communication with Marketing, Campbell Alliance conducted primary research to learn how organizations have reacted to their changing environments. Our findings and analysis are included in this article.
Read article

Debi Limones and Garry O'Grady
Providing effective training that addresses the emerging needs of today’s marketers is more important than ever. This white paper outlines some of the barriers to training that marketing organizations face and shows how companies can remove those barriers and achieve marketing excellence.
Read article

Lujing Wang
This white paper outlines the changes taking place in the global reimbursement environment, and their implications for pharma decision makers
Read article

Gary Tyson and Desiree Lau, Medical Affairs practice; Jay Jauregui, Trade & Distribution practice
Executives in our Medical Affairs and Trade practices shed light on the trends and challenges associated with REMS
Read article

Garry O’Grady
This article details the environmental shifts underway in the marketplace that are impacting or will impact sales representatives and the competencies that they will need to succeed in a changing landscape.
Read article

Gary Tyson
This article highlights the “three Ps” that organizations can address to improve the speed and quality of their protocol development process.
Read article

Gary Tyson and Mike Menta
This paper shares the top six insights to emerge from The Medical Affairs Leadership Summit on topics that include MA leadership in pre-launch products, Medical Science Liaison effectiveness, and MA involvement in product launches.
Read article